OHSU Cancer Institute Launches $1B Campaign with $500M Pledge | GenomeWeb

NEW YORK (GenomeWeb News) – The Knight Cancer Institute at Oregon Health and Science University said today that it has received a challenge pledge of $500 million to kick off a fundraising campaign to raise $1 billion to fund the cancer research center.

The funding from Nike Co-founder and Chairman Phil Knight and his wife Penny Knight was pledged to encourage others to help OHSU hit the $1 billion goal over the next two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.